Filing metadata

Accession number
0001213900-24-094630
Form type
Form 3
Filer
Actinium Pharmaceuticals, Inc.
CIK
CIK 1388320
Filed
Nov 05, 2024
Reporting period
Nov 01, 2024
Description
Initial ownership

Explore SEC Filings Hub